[1]
Andriawan, N.A. 2023. Pembrolizumab as A Therapy for Triple-Negative Breast Cancer : Systematic Review. Journal of Herbal, Clinical and Pharmaceutical Science (HERCLIPS). 5, 01 (Oct. 2023), 58–67. DOI:https://doi.org/10.30587/herclips.v5i01.6285.